Crispr Therapeutics AG vs Advanced Drainage Systems Inc — how do they compare? Crispr Therapeutics AG trades at $54.08 (market cap $5.23B), while Advanced Drainage Systems Inc trades at $143.7 (market cap $10.83B). The key difference: Advanced Drainage Systems Inc is far larger — about 2.1× Crispr Therapeutics AG's market cap, and Advanced Drainage Systems Inc pays a 0.56% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | WMS | |
|---|---|---|
Market Cap | $5.23B | $10.83B |
Sector | Health | Industrials |
52-Week High | $76.78 | $175.38 |
52-Week Low | $44.34 | $129.50 |
Enterprise Value | $3.65B | $12.44B |
Dividend Yield | — | 0.56% |
Trailing returns across standard periods
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →